Related Experiment Video

Updated: May 18, 2026

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
08:40

Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis

Published on: February 28, 2021

Tumefactive multiple sclerosis lesions under fingolimod treatment

Femke Visser1, Mike P Wattjes, Petra J W Pouwels

  • 1Department of Neurology, Sint Lucas Andreas Hospital, Amsterdam, the Netherlands. f.visser@slaz.nl

Neurology
|October 5, 2012
PubMed
Summary

No abstract available in PubMed .

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...